Brief: Wanbury says FDA successfully completes inspection at API facility in Patalganga plant
Sept 30 (Reuters) - Wanbury:
* Successful completion of USFDA inspection at its API
facility in Patalganga plant
* Audit was carried out for a period of 4 days from
september 26 to september 29, 2016 and concluded successfully
Source text: http://bit.ly/2cQp22h
(Bengaluru newsroom)
((ReutersIndia.snapping@thomsonreuters.com ;))
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility